KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bausch Health Companies (BHC) Change in Accured Expenses (2016 - 2026)

Bausch Health Companies' Change in Accured Expenses history spans 18 years, with the latest figure at -$150.0 million for Q1 2026.

On a quarterly basis, Change in Accured Expenses fell 51.52% to -$150.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$127.0 million, a 161.35% decrease, with the full-year FY2025 number at -$76.0 million, down 121.29% from a year prior.
Change in Accured Expenses hit -$150.0 million in Q1 2026 for Bausch Health Companies, up from -$284.0 million in the prior quarter.
Over the last five years, Change in Accured Expenses for BHC hit a ceiling of $166.0 million in Q3 2023 and a floor of -$284.0 million in Q4 2025.
Historically, Change in Accured Expenses has averaged $12.6 million across 5 years, with a median of $47.0 million in 2022.
Biggest five-year swings in Change in Accured Expenses: skyrocketed 737.5% in 2024 and later crashed 1283.33% in 2025.
Tracing BHC's Change in Accured Expenses over 5 years: stood at $47.0 million in 2022, then soared by 106.38% to $97.0 million in 2023, then tumbled by 75.26% to $24.0 million in 2024, then crashed by 1283.33% to -$284.0 million in 2025, then surged by 47.18% to -$150.0 million in 2026.
Business Quant data shows Change in Accured Expenses for BHC at -$150.0 million in Q1 2026, -$284.0 million in Q4 2025, and $144.0 million in Q3 2025.